Revision Skincare Appoints Lisa Paley CEO

Revision Skincare, a leader in advanced skincare solutions, has appointed Lisa Paley CEO.

Paley’s experience spans nearly three decades serving as an executive for Haleon, GSK, Pfizer and Johnson & Johnson.

“Lisa’s extensive experience building science-backed brands across the consumer health, wellness and beauty spectrum makes her the ideal leader to accelerate our business in the US and key global markets,” said Matt Farron, Partner, Co-Head of Consumer Group at Gryphon Investors. “She has a stellar reputation as a visionary leader who can deliver sustained growth, scale innovation across geographies and build high-performance cultures with an engaging, people-driven leadership style. We’re thrilled to welcome Lisa to lead Revision Skincare’s next stage of growth.”

As professional and consumer health and beauty trends continue to intersect, Paley will leverage her expertise building powerhouse consumer brands in the US and globally to reinvigorate Revision Skincare’s business and unlock its full potential. She joins the company from Haleon, the largest global consumer health company, where she served as president of North America and was a founding member of the executive leadership team. During her tenure, she led the company’s North American business through its landmark corporate spin-off from GSK and its public listings on both the NYSE and FTSE.

“I’m honored to join Revision Skincare as CEO at such an exciting time in the beauty industry, when we’re seeing consumer health and beauty trends converge in new ways,” said Paley. “Our brand has a powerful foundation of scientific innovation and proven results, and I look forward to building on that legacy to bring even more transformative skin health solutions to professionals and consumers. At Revision, we believe beauty and confidence come from skin that’s nurtured for the long term, and my goal is to extend our impact while staying true to our mission of delivering trusted, physician-dispensed skincare.”